1. Home
  2. UNCY vs MAGH Comparison

UNCY vs MAGH Comparison

Compare UNCY & MAGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • MAGH
  • Stock Information
  • Founded
  • UNCY 2016
  • MAGH 2012
  • Country
  • UNCY United States
  • MAGH Singapore
  • Employees
  • UNCY N/A
  • MAGH N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • MAGH Engineering & Construction
  • Sector
  • UNCY Health Care
  • MAGH Industrials
  • Exchange
  • UNCY Nasdaq
  • MAGH Nasdaq
  • Market Cap
  • UNCY 56.4M
  • MAGH 51.8M
  • IPO Year
  • UNCY 2021
  • MAGH 2025
  • Fundamental
  • Price
  • UNCY $4.70
  • MAGH N/A
  • Analyst Decision
  • UNCY Strong Buy
  • MAGH
  • Analyst Count
  • UNCY 4
  • MAGH 0
  • Target Price
  • UNCY $63.75
  • MAGH N/A
  • AVG Volume (30 Days)
  • UNCY 384.1K
  • MAGH 1.5M
  • Earning Date
  • UNCY 08-14-2025
  • MAGH 01-01-0001
  • Dividend Yield
  • UNCY N/A
  • MAGH N/A
  • EPS Growth
  • UNCY N/A
  • MAGH N/A
  • EPS
  • UNCY N/A
  • MAGH 0.03
  • Revenue
  • UNCY N/A
  • MAGH $13,529,576.00
  • Revenue This Year
  • UNCY N/A
  • MAGH N/A
  • Revenue Next Year
  • UNCY $1,178.98
  • MAGH N/A
  • P/E Ratio
  • UNCY N/A
  • MAGH $50.79
  • Revenue Growth
  • UNCY N/A
  • MAGH 10.71
  • 52 Week Low
  • UNCY $2.75
  • MAGH $1.45
  • 52 Week High
  • UNCY $11.00
  • MAGH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 52.02
  • MAGH N/A
  • Support Level
  • UNCY $3.97
  • MAGH N/A
  • Resistance Level
  • UNCY $4.43
  • MAGH N/A
  • Average True Range (ATR)
  • UNCY 0.25
  • MAGH 0.00
  • MACD
  • UNCY 0.10
  • MAGH 0.00
  • Stochastic Oscillator
  • UNCY 73.00
  • MAGH 0.00

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About MAGH Magnitude International Ltd Ordinary Shares

Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.

Share on Social Networks: